Profiel
Janice Marie McCourt is currently the Chief Executive Officer at Hudson Therapeutics, Inc. and the Chief Business Officer at Comera Life Sciences Holdings, Inc. Her former positions include Vice President-Business Development at Agenus, Inc., Scorpius Holdings, Inc., and Chief Business & Corporate Development Officer at Lyvgen Biopharma Holdings Ltd. She completed her undergraduate degree at Massachusetts College of Pharmacy & Health Science and holds an MBA from the University of Phoenix.
Actieve functies van Janice McCourt
| Bedrijven | Functie | Begin |
|---|---|---|
| COMERA LIFE SCIENCES HOLDINGS, INC. | Corporate Officer/Principal | 09-11-2022 |
Eerdere bekende functies van Janice McCourt
| Bedrijven | Functie | Einde |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Corporate Officer/Principal | 01-01-2019 |
Lyvgen Biopharma Holdings Ltd | Corporate Officer/Principal | - |
| AGENUS INC. | Corporate Officer/Principal | - |
Opleiding van Janice McCourt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
Lyvgen Biopharma Holdings Ltd |
















